⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Study of Niraparib in Patients With Ovarian Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

Official Title: A Phase 2, Open-Label, Single-Arm Study to Evaluate the Safety and Efficacy of Niraparib in Patients With Advanced, Relapsed, High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Who Have Received Three or Four Previous Chemotherapy Regimens

Study ID: NCT02354586

Interventions

Niraparib

Study Description

Brief Summary: This is a Phase 2, open-label, single arm study to evaluate the safety and efficacy of niraparib in ovarian cancer patients who have received three or four previous chemotherapy regimens. Niraparib is an orally active PARP inhibitor. Niraparib will be administered once daily continuously during a 28-day cycle. Health-related quality of life will be measured by Eastern Cooperative Oncology Group performance status (ECOG). Safety and tolerability will be assessed by clinical review of adverse events (AEs), physical examinations, electrocardiograms (ECGs), RECIST tumor assessments and safety laboratory values.

Detailed Description:

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: FEMALE

Healthy Volunteers: No

Locations

GSK Investigational Site, Chandler, Arizona, United States

GSK Investigational Site, Phoenix, Arizona, United States

GSK Investigational Site, Tucson, Arizona, United States

GSK Investigational Site, Burbank, California, United States

GSK Investigational Site, Duarte, California, United States

GSK Investigational Site, Los Angeles, California, United States

GSK Investigational Site, Los Angeles, California, United States

GSK Investigational Site, San Francisco, California, United States

GSK Investigational Site, Santa Barbara, California, United States

GSK Investigational Site, Stanford, California, United States

GSK Investigational Site, New Haven, Connecticut, United States

GSK Investigational Site, Tampa, Florida, United States

GSK Investigational Site, West Palm Beach, Florida, United States

GSK Investigational Site, Atlanta, Georgia, United States

GSK Investigational Site, Chicago, Illinois, United States

GSK Investigational Site, Chicago, Illinois, United States

GSK Investigational Site, Indianapolis, Indiana, United States

GSK Investigational Site, Indianapolis, Indiana, United States

GSK Investigational Site, Covington, Louisiana, United States

GSK Investigational Site, New Orleans, Louisiana, United States

GSK Investigational Site, Baltimore, Maryland, United States

GSK Investigational Site, Boston, Massachusetts, United States

GSK Investigational Site, Boston, Massachusetts, United States

GSK Investigational Site, Burlington, Massachusetts, United States

GSK Investigational Site, Ann Arbor, Michigan, United States

GSK Investigational Site, Minneapolis, Minnesota, United States

GSK Investigational Site, Rochester, Minnesota, United States

GSK Investigational Site, Springfield, Missouri, United States

GSK Investigational Site, Hackensack, New Jersey, United States

GSK Investigational Site, Morristown, New Jersey, United States

GSK Investigational Site, East Setauket, New York, United States

GSK Investigational Site, Jamaica, New York, United States

GSK Investigational Site, Lake Success, New York, United States

GSK Investigational Site, New York, New York, United States

GSK Investigational Site, Durham, North Carolina, United States

GSK Investigational Site, Oklahoma City, Oklahoma, United States

GSK Investigational Site, Medford, Oregon, United States

GSK Investigational Site, Wynnewood, Pennsylvania, United States

GSK Investigational Site, Providence, Rhode Island, United States

GSK Investigational Site, Nashville, Tennessee, United States

GSK Investigational Site, Austin, Texas, United States

GSK Investigational Site, Dallas, Texas, United States

GSK Investigational Site, Fort Worth, Texas, United States

GSK Investigational Site, San Antonio, Texas, United States

GSK Investigational Site, The Woodlands, Texas, United States

GSK Investigational Site, Tyler, Texas, United States

GSK Investigational Site, Spokane, Washington, United States

GSK Investigational Site, Tacoma, Washington, United States

GSK Investigational Site, Calgary, Alberta, Canada

GSK Investigational Site, Toronto, Ontario, Canada

GSK Investigational Site, Montreal, Quebec, Canada

GSK Investigational Site, Montreal, Quebec, Canada

GSK Investigational Site, Montreal, Quebec, Canada

GSK Investigational Site, Montreal, Quebec, Canada

GSK Investigational Site, Sherbrooke, Quebec, Canada

Contact Details

Name: GSK Clinical Trials

Affiliation: GlaxoSmithKline

Role: STUDY_DIRECTOR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: